|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
SCIDIR_ocn624333105 |
003 |
OCoLC |
005 |
20231117033135.0 |
006 |
m o d |
007 |
cr bn||||||abp |
007 |
cr bn||||||ada |
008 |
100519s1994 enka ob 001 0 eng d |
040 |
|
|
|a OCLCE
|b eng
|e pn
|c OCLCE
|d OCLCQ
|d UIU
|d OCLCQ
|d OCLCF
|d OCLCO
|d E7B
|d YDXCP
|d OCLCQ
|d CHVBK
|d STF
|d AU@
|d OCLCO
|d LUN
|d INARC
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCL
|d OCLCQ
|d OCLCO
|
015 |
|
|
|a GB9462511
|2 bnb
|
016 |
7 |
|
|a 000010447503
|2 AU
|
016 |
7 |
|
|a 9420558
|2 DNLM
|
019 |
|
|
|a 649980916
|a 899002729
|a 1057911915
|a 1176259019
|
020 |
|
|
|z 9780121988753
|q (alk. paper)
|
020 |
|
|
|z 0121988759
|q (alk. paper)
|
035 |
|
|
|a (OCoLC)624333105
|z (OCoLC)649980916
|z (OCoLC)899002729
|z (OCoLC)1057911915
|z (OCoLC)1176259019
|
042 |
|
|
|a dlr
|
050 |
|
4 |
|a RM370
|b .L57 1994
|
060 |
|
4 |
|a 1994 A-400
|
060 |
|
4 |
|a QU 85
|b L76325 1993
|
082 |
1 |
4 |
|a 616.97
|2 12
|
082 |
0 |
4 |
|a 615.7
|b L663
|2 20
|
084 |
|
|
|a 44.38
|2 bcl
|
084 |
|
|
|a 44.45
|2 bcl
|
084 |
|
|
|a XI 6600
|2 rvk
|
245 |
0 |
0 |
|a Lipid mediators /
|c edited by Fiona M. Cunningham.
|
260 |
|
|
|a London ;
|a San Diego :
|b Academic Press,
|c �1994.
|
300 |
|
|
|a 1 online resource (xii, 376 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Handbook of immunopharmacology. Cells and mediators
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|a Metabolism of arachidonic acid: an overview / A.L. Willis and D.L. Smith -- Measurement of fatty acids and their metabolites / G.W. Taylor and R. Wellings -- Biological properties of cyclooxygenase products / J.R. Vane and R.M. Botting -- Other essential fatty acids, their metabolites and cell-cell interactions / M.R. Buchanan and S.J. Brister -- Inhibitors of fatty acid-derived mediators / D.W.P. Hay and D.E. Griswold -- Biosynthesis and catabolism of platelet-activating factor / F. Snyder -- Cellular sources of platelet-activating factor and related lipids / D.L. Bratton, K.L. Clay and P.M. Henson -- Biological properties of platelet-activating factor / A.G. Stewart -- Platelet-activating factor: receptors and receptor antagonists / S.-B. Hwang.
|
506 |
|
|
|3 Use copy
|f Restrictions unspecified
|2 star
|5 MiAaHDL
|
533 |
|
|
|a Electronic reproduction.
|b [Place of publication not identified] :
|c HathiTrust Digital Library,
|d 2010.
|5 MiAaHDL
|
538 |
|
|
|a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.
|u http://purl.oclc.org/DLF/benchrepro0212
|5 MiAaHDL
|
583 |
1 |
|
|a digitized
|c 2010
|h HathiTrust Digital Library
|l committed to preserve
|2 pda
|5 MiAaHDL
|
588 |
0 |
|
|a Print version record.
|
650 |
|
0 |
|a Immunopharmacology.
|
650 |
|
0 |
|a Lipids
|x Metabolism.
|
650 |
|
2 |
|a Lipid Metabolism
|0 (DNLM)D050356
|
650 |
|
6 |
|a Immunopharmacologie.
|0 (CaQQLa)201-0072475
|
650 |
|
6 |
|a Lipides
|x M�etabolisme.
|0 (CaQQLa)201-0025368
|
650 |
|
7 |
|a Lipids
|x Metabolism
|2 fast
|0 (OCoLC)fst00999374
|
650 |
|
7 |
|a Immunopharmacology
|2 fast
|0 (OCoLC)fst00968030
|
650 |
|
7 |
|a Lipide
|2 gnd
|0 (DE-588)4035873-2
|
650 |
|
7 |
|a Mediator
|2 gnd
|0 (DE-588)4132052-9
|
650 |
1 |
7 |
|a Immunologie.
|2 gtt
|
650 |
1 |
7 |
|a Farmacologie.
|2 gtt
|
653 |
0 |
|
|a Humans
|a Immune system
|a Diseases
|
700 |
1 |
|
|a Cunningham, Fiona M.
|
776 |
0 |
8 |
|i Print version:
|t Lipid mediators.
|d London ; San Diego : Academic Press, �1994
|w (OCoLC)30057728
|
830 |
|
0 |
|a Handbook of immunopharmacology.
|p Cells and mediators.
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780121988753
|z Texto completo
|